The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Sox2 expression in breast tumours and activation in breast cancer stem cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M. A., & Daidone, M. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0626 · Cited by 1,723
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S. (2009) · Nature · doi:10.1038/nature08235 · Cited by 1,301
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102454108 · Cited by 1,147
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
Fillmore, C. M., & Kuperwasser, C. (2008) · Breast Cancer Research · doi:10.1186/bcr1982 · Cited by 1,033
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., & Blasco, M. A. (2009) · Nature · doi:10.1038/nature08287 · Cited by 1,028 · cited 2×
“Recently, the process of reprogramming and tumourigenesis (Kawamura et al., 2009; Li et al., 2009; Marion et al., 2009; Utikal et al., 2009) have been linked as the p53 tumour suppressor, one of the main regulators of oncogenic transformation, controls the induction of pluripotency.”
BackgroundThe Ink4/Arf locus is a barrier for iPS cell reprogramming
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., Blasco, M. A., & Serrano, M. (2009) · Nature · doi:10.1038/nature08290 · Cited by 968
Patrawala, L., Calhoun, T., Schneider-Broussard, R., Zhou, J., Claypool, K., & Tang, D. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0592 · Cited by 903
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
Utikal, J., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., & Hochedlinger, K. (2009) · Nature · doi:10.1038/nature08285 · Cited by 836
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., Minucci, S., Di Fiore, P. P., & Pelicci, P. G. (2009) · Cell · doi:10.1016/j.cell.2009.06.048 · Cited by 696
Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 643
Gangemi, R. M. R., Griffero, F., Marubbi, D., Perera, M., Capra, M. C., Malatesta, P., Ravetti, G. L., Zona, G. L., Daga, A., & Corte, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0493 · Cited by 578
Direct reprogramming of human neural stem cells by OCT4
Kim, J. B., Greber, B., Araúzo-Bravo, M. J., Meyer, J., Park, K. I., Zaehres, H., & Schöler, H. R. (2009) · Nature · doi:10.1038/nature08436 · Cited by 577
Tanei, T., Morimoto, K., Shimazu, K., Kim, S. J., Tanji, Y., Taguchi, T., Tamaki, Y., & Noguchi, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1479 · Cited by 574
Abraham, B. K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., & Brauch, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1154.11.3 · Cited by 527
Zeng, Y. A., & Nusse, R. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.020 · Cited by 396
The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer
Chen, Y., Shi, L., Zhang, L., Li, R., Liang, J., Yu, W., Sun, L., Yang, X., Wang, Y., Zhang, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802917200 · Cited by 358
Zappone, M. V., Galli, R., Catena, R., Meani, N., Biasi, S. D., Mattei, E., Tiveron, C., Vescovi, A. L., Lovell-Badge, R., Ottolenghi, S., et al. (2000) · Development · doi:10.1242/dev.127.11.2367 · Cited by 348
Farnie, G., Clarke, R. B., Spence, K., Pinnock, N., Brennan, K., Anderson, N. G., & Bundred, N. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk133 · Cited by 313
Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53 –Mediated Mouse Mammary Tumors
Shafee, N., Smith, C. R., Wei, S., Kim, Y., Mills, G. B., Hortobagyi, G. N., Stanbridge, E. J., & Lee, E. Y.-H. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5480 · Cited by 308
Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex
Tomioka, M. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf435 · Cited by 307
Papapetrou, E. P., Tomishima, M. J., Chambers, S. M., Mica, Y., Reed, E., Menon, J., Tabar, V., Mo, Q., Studer, L., & Sadelain, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904825106 · Cited by 286
Kidder, B. L., Palmer, S., & Knott, J. G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0710 · Cited by 242
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer
Rodriguez-Pinilla, S. M., Sarrio, D., Moreno-Bueno, G., Rodriguez-Gil, Y., Martinez, M. A., Hernandez, L., Hardisson, D., Reis-Filho, J. S., & Palacios, J. (2007) · Modern Pathology · doi:10.1038/modpathol.3800760 · Cited by 242
Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors
Yamanaka, S. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00493.x · Cited by 241
Güre, A. O., Stockert, E., Scanlan, M. J., Keresztes, R. S., Jäger, D., Altorki, N. K., Old, L. J., & Chen, Y.-T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4198 · Cited by 234
Liu, M., Sakamaki, T., Casimiro, M. C., Willmarth, N. E., Quong, A. A., Ju, X., Ojeifo, J., Jiao, X., Yeow, W.-S., Katiyar, S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0732 · Cited by 227
Engelmann, K., Shen, H., & Finn, O. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2249 · Cited by 216
Kondo, T., & Raff, M. (2004) · Genes & Development · doi:10.1101/gad.309404 · Cited by 212
NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells
Zhou, J., Zhang, H., Gu, P., Bai, J., Margolick, J. B., & Zhang, Y. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9798-y · Cited by 201
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway
洪, 炫. (2012) · Medical Entomology and Zoology · Cited by 198
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
Lengerke, C., Fehm, T., Kurth, R., Neubauer, H., Scheble, V., Müller, F., Schneider, F., Petersen, K., Wallwiener, D., Kanz, L., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-42 · Cited by 194
Oct4 pseudogenes are transcribed in cancers
Suo, G., Han, J., Wang, X., Zhang, J., Zhao, Y., Zhao, Y., & Dai, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.157 · Cited by 194
Molecular Classification of Breast Carcinomas Using Tissue Microarrays
Callagy, G., Cattaneo, E., Daigo, Y., Happerfield, L., Bobrow, L. G., Pharoah, P. D. P., & Caldas, C. (2003) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200303000-00004 · Cited by 171
Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors
Akala, O. O., Park, I.-K., Qian, D., Pihalja, M., Becker, M. W., & Clarke, M. F. (2008) · Nature · doi:10.1038/nature06869 · Cited by 169
Sox2 Protein Expression is an Independent Poor Prognostic Indicator in Stage I Lung Adenocarcinoma
Sholl, L. M., Barletta, J. A., Yeap, B. Y., Chirieac, L. R., & Hornick, J. L. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181e5e024 · Cited by 156
Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma
Li, X., Eishi, Y., Bai, Y.-Q., Sakai, H., Akiyama, Y., Tani, M., Takizawa, T., Koike, M., & Yuasa, Y. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.2.257 · Cited by 143
Ghods, A. J., Irvin, D. K., Liu, G., Yuan, X., Abdulkadir, I. R., Tunici, P., Konda, B. M., Wachsmann‐Hogiu, S., Black, K. L., & Yu, J. S. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0624 · Cited by 143
Absence of OCT4 Expression in Somatic Tumor Cell Lines
Cantz, T., Key, G., Bleidiβel, M., Gentile, L., Han, D., Brenne, A., & Schöler, H. R. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0657 · Cited by 119
NANOGP8 is a retrogene expressed in cancers
Zhang, J., Wang, X., Li, M., Han, J., Chen, B., Wang, B., & Dai, J. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05186.x · Cited by 119
Effects of estrogen on the proportion of stem cells in the breast
Simões, B. M., Piva, M., Iriondo, O., Comaills, V., López-Ruiz, J. A., Zabalza, I., Mieza, J. A., Acinas, O., & Vivanco, M. D. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1169-4 · Cited by 114
Miyagi, S., Saito, T., Mizutani, K., Masuyama, N., Gotoh, Y., Iwama, A., Nakauchi, H., Masui, S., Niwa, H., Nishimoto, M., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4207-4220.2004 · Cited by 101
The Sox2 Regulatory Region 2 Functions as a Neural Stem Cell-specific Enhancer in the Telencephalon
Miyagi, S., Nishimoto, M., Saito, T., Ninomiya, M., Sawamoto, K., Okano, H., Muramatsu, M., Oguro, H., Iwama, A., & Okuda, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512669200 · Cited by 99
Katoh, M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794295710 · Cited by 99
Regulation of Nuclear Factor κB Transactivation
Martín, Á. G., San-Antonio, B., & Fresno, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011313200 · Cited by 96
Comtesse, N., Zippel, A., Walle, S., Monz, D., Backes, C., Fischer, U., Mayer, J. M., Ludwig, N., Hildebrandt, A., Keller, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500404102 · Cited by 79
Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells
Ambady, S., Malcuit, C. M., Kashpur, O., Kole, D., Holmes, W. F., Hedblom, E., Page, R. L., & Dominko, T. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103192sa · Cited by 74
Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
Ao, A. S., Morrison, B. J., Wang, H., López, J. A., Reynolds, B. A., & Lu, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018810 · Cited by 39
Cited by
Zhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 971
Hypoxia-inducible factors: cancer progression and clinical translation
Wicks, E. E., & Semenza, G. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159839 · Cited by 580
Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications
Ishiguro, T., Ohata, H., Sato, A., Yamawaki, K., Enomoto, T., & Okamoto, K. (2017) · Cancer Science · doi:10.1111/cas.13155 · Cited by 530
Erin, N., Grahovac, J., Brozovic, A., & Efferth, T. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100715 · Cited by 527
The role of SOX family members in solid tumours and metastasis
Grimm, D., Bauer, J., Wise, P., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.004 · Cited by 487
Metadata
- Authors
- Leis, O., Eguiara, A., Lopez-Arribillaga, E., Alberdi, M. J., Hernandez-Garcia, S., Elorriaga, K., Pandiella, A., Rezola, R., & Martin, A. G.
- Venue
- Oncogene
- Published
- 2011-08-08
- Volume
- 31
- Issue
- 11
- Pages
- 1354-1365
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2079777624
- Cited by
- 514
- References
- 60
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.